Cargando…

The impact of the COVID-19 pandemic on the global tuberculosis epidemic

Tuberculosis (TB) is a major cause of ill health worldwide. Until the coronavirus (COVID-19) pandemic, TB was the leading cause of death from a single infectious agent. COVID-19 has caused enormous health, social and economic upheavals since 2020, impairing access to essential TB services. In marked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falzon, Dennis, Zignol, Matteo, Bastard, Mathieu, Floyd, Katherine, Kasaeva, Tereza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546619/ https://www.ncbi.nlm.nih.gov/pubmed/37795102 http://dx.doi.org/10.3389/fimmu.2023.1234785

Ejemplares similares

Global reporting on tuberculosis preventive treatment among contacts
por: Falzon, Dennis, et al.
Publicado: (2022)

Multidrug-resistant tuberculosis in children: evidence from global surveillance
por: Zignol, Matteo, et al.
Publicado: (2013)

25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward
por: Dean, Anna S, et al.
Publicado: (2022)

Achieving universal access to rapid tuberculosis diagnostics
por: Ismail, Nazir, et al.
Publicado: (2023)

Scaling Up TB Screening and TB Preventive Treatment Globally: Key Actions and Healthcare Service Costs
por: Satyanarayana, Srinath, et al.
Publicado: (2023)

Priorities for global political momentum to end TB: a critical point in time
por: Kasaeva, Tereza, et al.
Publicado: (2018)

Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets — Worldwide, 2019
por: Fukunaga, Rena, et al.
Publicado: (2021)

Framework for the evaluation of new tests for tuberculosis infection
por: Hamada, Yohhei, et al.
Publicado: (2021)

Wider access to quality-assured rifapentine-based regimens is needed to accelerate tuberculosis prevention and care globally
por: Masini, Tiziana, et al.
Publicado: (2022)

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
por: Mirzayev, Fuad, et al.
Publicado: (2021)

Multidrug-resistant tuberculosis around the world: what progress has been made?
por: Falzon, Dennis, et al.
Publicado: (2015)

Call to action for an invigorated drive to scale up TB prevention
por: Kasaeva, T., et al.
Publicado: (2021)

Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
por: Brigden, Grania, et al.
Publicado: (2019)

Multidrug-Resistant Tuberculosis, Somalia, 2010–2011
por: Sindani, Ireneaus, et al.
Publicado: (2013)

Advances in clinical trial design: Weaving tomorrow’s TB treatments
por: Lienhardt, Christian, et al.
Publicado: (2020)

The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Modernizing Surveillance of Antituberculosis Drug Resistance: From Special Surveys to Routine Testing
por: Zignol, Matteo, et al.
Publicado: (2011)

Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
por: Grifoni, Alba, et al.
Publicado: (2023)

Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data
por: Dean, Anna S., et al.
Publicado: (2020)

Target product profiles: tests for tuberculosis treatment monitoring and optimization
por: Gupta-Wright, Ankur, et al.
Publicado: (2023)

The impact of the COVID-19 epidemic on tuberculosis control in China
por: Fei, Huang, et al.
Publicado: (2020)

Tuberculosis: an ongoing global epidemic
Publicado: (2021)

Controlling the HIV/AIDS epidemic: current status and global challenges
por: Demberg, Thorsten, et al.
Publicado: (2012)

Global transmission of monkeypox virus—a potential threat under the COVID-19 pandemic
por: Wang, Yang, et al.
Publicado: (2023)

Recommendation mapping of the World Health Organization's guidelines on tuberculosis: A new approach to digitizing and presenting recommendations
por: Hajizadeh, Anisa, et al.
Publicado: (2021)

Ambulatory-Based Standardized Therapy for Multi-Drug Resistant Tuberculosis: Experience from Nepal, 2005–2006
por: Malla, Pushpa, et al.
Publicado: (2009)

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic
por: Dass, Sylvia Annabel, et al.
Publicado: (2022)

Disseminated tuberculosis in a child during the COVID-19 pandemic: a case report and literature review
por: Weng, Taoping, et al.
Publicado: (2023)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

Animal models for COVID-19 and tuberculosis
por: Corleis, Björn, et al.
Publicado: (2023)

Global tuberculosis progress reversed by COVID-19 pandemic
por: Kirby, Tony
Publicado: (2021)

The impact of COVID-19 on global tuberculosis control
por: Lipman, Marc, et al.
Publicado: (2021)

Immune damage mechanisms of COVID-19 and novel strategies in prevention and control of epidemic
por: Sun, Yuting, et al.
Publicado: (2023)

Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
por: Jenkins, Helen E., et al.
Publicado: (2011)

Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel
por: Marcus, Nufar, et al.
Publicado: (2021)

A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose
por: Linas, Benjamin P., et al.
Publicado: (2021)

Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets — 2017
por: MacNeil, Adam, et al.
Publicado: (2019)

Back to the future, again: greater leadership, collaboration and accountability to accelerate progress to end TB
por: Weil, Diana, et al.
Publicado: (2018)

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
por: Gonzalo-Asensio, Jesus, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_roi7t2b0g0a7d18v08aa67d7do